POLYNEURON
Polyneuron is a developer of novel therapeutics intended to facilitate the treatment of antibody-mediated autoimmune diseases. The company's biodegradable glycopolymers-based therapeutics selectively eliminate the pathological autoantibodies, while leaving the rest of the immune system intact, enabling medical practitioners to treat patients with immune disorders in a safe and effective manner.
POLYNEURON
Industry:
Biotechnology Communities Medical Medical Device
Founded:
2014-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.polyneuron.com
Total Employee:
1+
Status:
Active
Contact:
+41788371011
Email Addresses:
[email protected]
Total Funding:
43.34 M CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default WordPress Nginx PHP PHP 7 Sectigo SSL Sectigo Domain SSL
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
New Enterprise Associates
New Enterprise Associates investment in Series A - POLYNEURON
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series A - POLYNEURON
Sofinnova Partners
Sofinnova Partners investment in Series A - POLYNEURON
New Enterprise Associates
New Enterprise Associates investment in Series A - POLYNEURON
Sofinnova Partners
Sofinnova Partners investment in Series A - POLYNEURON
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Seed Round - POLYNEURON
EVA Basel
EVA Basel investment in Seed Round - POLYNEURON
BaseLaunch
BaseLaunch investment in Grant - POLYNEURON
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Seed Round - POLYNEURON
EVA Basel
EVA Basel investment in Seed Round - POLYNEURON
Key Employee Changes
Date | New article |
---|---|
2020-10-06 | Polyneuron Appoints Aled Williams as Chief Business Officer |